Goldman Sachs’s Aligos Therapeutics ALGS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.8K | Buy |
+10,231
| New | +$73.8K | ﹤0.01% | 4936 |
|
|
2022
Q4 | – | Sell |
-14,043
| Closed | -$15K | – | 5142 |
|
|
2022
Q3 | $15K | Sell |
14,043
-84,916
| -86% | -$90.7K | ﹤0.01% | 5211 |
|
|
2022
Q2 | $120K | Sell |
98,959
-32,203
| -25% | -$39.1K | ﹤0.01% | 5062 |
|
|
2022
Q1 | $282K | Buy |
131,162
+101,577
| +343% | +$218K | ﹤0.01% | 4916 |
|
|
2021
Q4 | $351K | Buy |
29,585
+5,848
| +25% | +$69.4K | ﹤0.01% | 4707 |
|
|
2021
Q3 | $368K | Sell |
23,737
-14,231
| -37% | -$221K | ﹤0.01% | 4547 |
|
|
2021
Q2 | $774K | Sell |
37,968
-3,795
| -9% | -$77.4K | ﹤0.01% | 4188 |
|
|
2021
Q1 | $950K | Buy |
+41,763
| New | +$950K | ﹤0.01% | 3945 |
|